Epidemiology Research InternationalVolume 2014 (2014), Article ID 974693, 7 pageshttp://dx.doi.org/10.1155/2014/974693

Research Article

Factors Associated with a Poor Treatment Outcome among Children Treated for Malaria in Ibadan, Southwest Nigeria

Adesola O. Sangowawa, Olukemi K. Amodu, Subulade A. Olaniyan, Folakemi A. Amodu, Peter E. Olumese, and Olayemi O. Omotade

Institute of Child Health, College of Medicine, University of Ibadan, Ibadan 200001, Nigeria

Received 27 October 2013; Revised 14 January 2014; Accepted 15 January 2014; Published 26 February 2014

Academic Editor: M. L. Wilson

Copyright © 2014 Adesola O. Sangowawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

We present data on factors associated with poor treatment outcome (death or recovery with a neurological complication) among children treated for malaria in Ibadan, Nigeria. A total of 2468 children (1532 with uncomplicated and 936 with severe malaria) were recruited from three government facilities. History was obtained from caregivers and malarial parasite test was carried out on each child. About 76.0% of caregivers had instituted home treatment. Following treatment, 2207 (89.5%) children recovered without complications, 9.1% recovered with neurological complications, and 1.4% died. The possibility of poor treatment outcome increased with decreasing child’s age (). A statistically significant proportion of children with pallor, jaundice, hepatomegaly, splenomegaly, respiratory distress, and severe anaemia had poor treatment outcome. Following logistic regression, child’s age < 12 months compared to older age groups (O.R = 5.99, 95% C.I = 1.15–31.15, and ) and loss of consciousness (O.R = 4.55, 95% CI = 1.72–12.08, and ) was significantly associated with poor treatment outcome. We recommend interventions to improve caregivers’ awareness on the importance of seeking medical care early. This will enhance early diagnosis and treatment and reduce the likelihood of complications that lead to poor treatment outcomes.

1. Introduction

Malaria remains an important cause of morbidity and mortality in Africa in spite of all efforts at prevention and control. In 2010, there were about 660, 000 malaria deaths around the world and, of these, approximately 86% were in children under five years of age [1]. The majority of cases (up to 80%) and deaths (up to 90%) due to malaria occur in Africa [1]. Malaria is still endemic in Nigeria with 97% of the population at risk of infection [2]. Findings from the 2010 Malaria Indicator Survey showed that about four out of ten children aged between six months and five years in Nigeria tested positive to malaria by blood smear test [3]. The Federal Ministry of Health estimates that every year malaria accounts for up to 110 million clinically diagnosed cases, 60% of outpatient visits, 30% of all hospitalizations, and more than 300,000 child deaths [2]. In addition to the high mortality, many children with the disease go on to develop short and long term complications such as anaemia, metabolic acidosis, hypoglycemia, hyperlacticacidemia, seizures, febrile convulsion and other complications affecting the central nervous system [4–6]. A number of factors have been suggested as predisposing to development of poor treatment outcomes among children with malaria. These include impaired consciousness, respiratory distress, hypoglycemia, and jaundice [7]. Knowledge of the factors that influence the outcome of malaria treatment is important in management of children with malaria in order to minimize morbidity and mortality from the disease. The paper discusses the factors associated with a poor outcome in children treated for malaria in Ibadan, Southwest Nigeria. Data for this paper was part of a larger study on genetic diversity and severe malaria.

2. Materials and Methods

The study was carried out in Ibadan, a city in southwest of Nigeria, a holoendemic area for malaria between 2007 and 2010. At the time of the study, the standard first-line treatment for uncomplicated malaria was artemether-lumefantrine or another artemisinin-based combination therapy. Drugs recommended for severe malaria included the following: quinine, artemether, or artesunate. These are to be commenced parenterally and changed to oral administration once the patient can take the drugs orally [8]. However, chloroquine injection and tablets were still available and could be purchased over-the-counter in drug stores within the country.

Children were recruited from the children’s emergency ward of the University College Hospital, Ibadan, the Adeoyo Maternity Hospital, Ibadan, and the Oni Memorial Hospital, Ibadan. A total of 2468 children who were diagnosed with malaria (children presenting with fever and who had a positive malaria parasite test result or a clinical diagnosis of malaria) were recruited. Clinical categorization of all eligible children into “uncomplicated malaria (UM),” and “severe malaria” groups was done using World Health Organization criteria (WHO 2000). According to the WHO classification, cases of severe malaria included those with impaired consciousness, cerebral malaria, severe malaria anaemia, and jaundice [9]. Children were excluded from the study if informed consent was not obtained from a relative (primary caregiver) or if an alternative diagnosis was made clinically or by investigation (such as cerebrospinal fluid examination, chest radiography, or blood culture). All the children were managed in line with the National Malaria Treatment Policy [8]. All the 936 children with severe malaria were hospitalised and treated with quinine according to the National Malaria Treatment Policy, that is, parenteral quinine which was changed to oral as soon as the child was able to tolerate it orally [8]. Those with uncomplicated malaria were treated on an outpatient basis with an ACT. Their caregivers were asked to bring them back on days 2, 7, and 14 for follow-up which included a clinical assessment and repeat malaria parasite test. In line with routine care, caregivers were asked to return to hospital immediately if there was no improvement in symptoms or if their child’s health got worse. Children with an initial diagnosis of uncomplicated malaria who subsequently presented with symptoms of severe malaria were admitted and treated appropriately as cases of severe malaria.

Ethical approval was obtained from the Joint University of Ibadan/University College Hospital, Ibadan Ethical Committee, and from the Oyo State Health board. Informed consent was obtained from the parents or guardian of the patients prior to recruitment.

Demographic information, clinical history information obtained from caregivers of children, and clinical examination done were recorded in a well-structured case record form. Patients body temperature was categorized as normal (36.6–37.2°C), febrile (>37.2°C), subnormal (36.6–35°C), and hypothermia (< 35°C) [10]. Thick blood smears stained with giemsa were prepared for each child and examined for trophozoites of P. falciparum. Parasite densities were calculated based on assumed total WBC of 8000/μL. Blood films were defined as negative if there were no asexual forms of P. falciparum in 100 high power fields examined. The parasite densities were log transformed and the geometric means of the parasite densities were calculated. Blood was also sampled for haematocrit or packed cell volume (PCV). Patients were classified as having severe (PCV ≤ 15%), moderate (PCV = 16–23%), mild (PCV = 24–33%), and no (PCV > 33%) anaemia. The Pediatric Glasgow Coma Scale was used to assess level of consciousness [11].

Statistical analysis was done with the SPSS 16.0 for Windows (SPSS Inc., Chicago, USA). The prevalence of malaria parasitaemia, spleen rate, liver rates, and anaemia (PCV < 33%) was calculated as a proportion of children with those indices. Poor treatment outcome was defined as recovery (resolution of fever, recovery of consciousness in children who were unconscious, and negative blood film) with a neurological complication at discharge or death. Chi-square was used for association between categorical variables. Logistic regression was used to determine the predictors of poor treatment outcome. Statistical significance was set at .

3. Results

Results of 2468 children aged 1–156 months, of mean age months, are presented. There were slightly more male (53.35) than female (46.7%) patients. The highest level of education of 49.0% of respondents’ mothers and 51.1% of their fathers was secondary education and majority of the parents (71.8% of mothers and 63.7% of fathers) were semiskilled workers.

The medical histories of the children are shown in Table 1. The commonest symptoms that patients presented with were fever (97.9%), rigors (17.8%), loss of appetite (39.1%), cough (33.1%), and vomiting (30.1%). About 17.0% of caregivers reported that their children were pale and three percent were jaundiced (described by caregivers as yellowness of their child’s eyes) prior to presentation in hospital. More than 200 (8.5%) presented with a history of loss of consciousness and 535 (21.7%) had at least an episode of convulsion prior to presentation in the health facility. More than three-quarters of caregivers (76.3%) had instituted some home treatments, of which the majority 1,457 (65.1%) gave paracetamol (PCM). Drugs also administered by mothers were chloroquine—CQ (16%), amodiaquine—AQ (4%), and others, including sulphadoxine-Pyrimethamine—SP (15%). Only 340 of the caregivers (15.4%) had not had a prior visit to a health provider such as a private hospital (19.2%), health centre (24.7%), patent medicine vendors (39.5%), and others (1.2%). The median number of days of onset of illness prior to a hospital visit was three. Two hundred and sixty-two children were reportedly semiconscious when they arrived to the hospital.

Table 1: Child’s medical history and history of illness.

Illness history

%

Symptoms prior to presentation (multiple responses) ()

    Fever
2415
97.9

    Loss of appetite
966
39.1

    Cough
819
33.1

    Vomiting
890
30.1

    Convulsion
535
21.7

    Catarrh
485
19.7

    Rigors
438
17.8

    Pallor
409
16.6

    Lethargy
339
13.7

    Loss of consciousness
211
8.5

    Fast breathing
161
6.5

    Diarrhoea
157
6.4

    Body aches
154
6.2

    Irritability
99
4.0

    Jaundice
76
3.0

Any home treatment ()

    Yes
1872
76.3

    No
579
23.7

Level of consciousness (Paediatric Glasgow Coma Scale) ()

    15 (normal)
76
12.5

    8–14 (altered sensorium)
462
75.7

    7 and below (coma)
72
11.8

Clinical examination of the children at presentation revealed that 21.3% were pale and 3.7% were jaundiced. In all, 1532 (62.1%) of children were diagnosed with uncomplicated malaria and 936 (37.9%) were diagnosed with severe malaria. The mean parasite density was [ among those with severe malaria and among those with uncomplicated malaria ]. All the 2468 children were treated in line with malaria treatment guidelines. The 936 children diagnosed with severe malaria were admitted to hospital and treated with quinine (initially parenteral then changed to oral). The majority, 2207 (89.5%), of all 2468 children recovered fully without any neurological or other complications, 9.1% recovered but with neurological complications such as seizures and hearing deficit, and 1.4% died.

3.1. Sociodemographic Factors Associated with Treatment Outcome

Sociodemographic factors associated with a negative treatment outcome, recovery with a neurological complication (NC), or death are presented in Table 2. Child’s age as well as the mother and fathers’ level of education was significantly associated with an adverse treatment outcome. The possibility of adverse health income increased with decrease in child’s age (). The higher the level of education of a child’s mother or father is, the less likely the occurrence of an adverse outcome will be ().

Table 2: Sociodemographic factors associated with treatment outcome.

Full recovery
Recovery + NC or death
Chi-square
value

Sex ()

    Male
1168 (88.8)
147 (11.2)
1.369
0.263

    Female
1039 (90.3)
112 (9.7)

Age group (months)

    <12
193 (74.8)
65 (25.2)
81.014
<0.0001*

    12–23
425 (88.2)
57 (11.8)

    24–35
402 (89.5)
47 (10.5)

    36–47
333 (92.0)
29 (8.0)

    48–59
278 (95.2)
14 (4.8)

    ≥60
576 (92.9)
44 (7.1)

Mother’s level of education ()

    No formal
83 (50.9)
80 (49.1)
301.3
<0.0001*

    Primary
528 (83.3)
106 (16.7)

    Secondary
1137 (95.1)
58 (4.9)

    Tertiary
455 (99.3)
3 (0.7)

Father’s level of education ()

    No formal
51 (49.5)
52 (50.5)
303.251
<0.0001*

    Primary
349 (76.4)
108 (23.6)

    Secondary
1168 (93.9)
76 (6.1)

    Tertiary
627 (99.4)
4 (0.6)

NC: neurological complications.

Statistically significant.

3.2. Association between Illness History and Treatment Outcome

Illness history and prior treatment associated with a negative treatment outcome, recovery with a NC, or death are presented in Table 3. Use of PCM prior to presentation was significantly associated with a better treatment outcome (). More children with a history of jaundice, loss of consciousness, and convulsion had a negative treatment outcome (). However, more of those who did not have a history of rigors (11.2%, ), loss of appetite (13.6%, ), vomiting (11.5%, ), or pallor (11.1%, ) had negative treatment outcomes.

Table 3: Illness history associated with outcome.

Full recovery
Recovery + NC or death
Chi-square
value

Any home treatment

Yes
1683 (89.9)
189 (10.1)

No
524 (90.5)
55 (9.5)
0.936
0.776

Any drug used prior to presentation ()

Yes
1553 (98.9)
17 (1.1)

No
649 (96.9)
21 (3.1)
11.852
0.001

Drug used prior to presentation

PCM

    Yes
1442 (99.0)
15 (1.0)

    No
757 (97.1)
23 (2.9)
11.206
0.001

CQ

    Yes
346 (98.3)
6 (1.7)

    No
1853 (98.3)
32 (1.7)
0.000
1.000

AQ (2237)

    Yes
93 (97.9)
2 (2.1)

    No
2106 (98.3)
36 (1.7)
0.098
1.000

SP

    Yes
21 (95.5)
1 (4.5)

    No
2178 (98.3)
37 (1.7)
1.078
0.315

Symptoms prior to presentation

Fever ()

    Yes
2165 (89.6)
250 (10.4)
2.426
0.116

    No
44 (83.0)
9 (17.0)

Rigors ()

    Yes
407 (92.9)
31 (7.1)
6.618
0.010*

    No
1802
228 (11.2)

Loss of appetite ()

    Yes
912 (94.4)
54 (5.6)
40.644
<0.0001*

    No
1297 (86.4)
205 (13.6)

Vomiting ()

    Yes
812 (91.2)
78 (8.8)
4.437
0.040*

    No
1397 (88.5)
181 (11.5)

Diarrhoea ()

    Yes
142 (90.4)
15 (9.6)
0.158
0.788

    No
2067 (89.4)
244 (10.6)

Jaundice ()

    Yes
56 (73.7)
20 (26.3)

    No
2153 (90.0)
239 (10.0)
20.897
0.0001*

Pallor ()

    Yes
379 (92.7)
30 (7.3)
5.222
0.022*

    No
1829 (88.9)
229 (11.1)

Fast breathing ()

    Yes
140 (87.0)
21 (13.0)
1.192
0.286

    No
2069 (89.7)
238 (10.3)

Lethargy ()

    Yes
298 (87.9)
41 (12.1)
1.071
0.295

    No
1911 (89.8)
218 (10.2)

Loss of consciousness ()

    Yes
197 (93.4)
14 (6.6)
34.069
<0.0001*

    No
2005 (98.8)
24 (1.2)

Convulsion ()

    Yes
449 (83.9)
86 (16.1)
22.566
<0.0001*

    No
1758 (91.0)
173 (9.0)

Statistically significant.

3.3. Association between Clinical Examination and Laboratory Findings and Treatment Outcome

Negative treatment outcome was observed more in patients with pallor (19%, ), jaundice (33.3%, ), subnormal temperature (20.0%, ), hepatomegaly (26.7%, ), splenomegaly (26.9%, ), and severe anaemia defined as PCV ≤ 15% (20.1%, ) at presentation than among their counterparts who did not have these findings on examination at the hospital (see Table 4).

Table 4: Examination findings at presentation associated with outcome.

Full recovery
Recovery with NC or death
Chi-square
value

Pallor ()

    Yes
423 (81.0)
99 (19.0)
51.096
<0.0001*

    No
1766 (91.8)
157 (8.2)

Jaundice ()

    Yes
60 (66.7)
30 (33.3)
53.820
<0.0001*

    No
2130 (90.6)
221 (9.4)

Temperature (°C)

    Febrile (>37.2)
1133 (88.1)
153 (11.9)

    Normal     (36.6–37.2)
1032 (94.7)
58 (5.3)

    Subnormal     (36.6–35)
8 (80.0)
2 (20.0)

    Hypothermia     (<35)
5 (100.0)
0
34.581
<0.0001*

Paediatric GCS

    ≤7
68 (94.4)
4 (5.6)

    8–14
439 (95.0)
23 (5.0)

    15
73 (96.1)
3 (3.9)
0.219
0.896

Hepatomegaly ()

    Yes
381 (73.3)
139 (26.7)
255.3
<0.0001*

    No
1722 (96.3)
70 (3.9)

Splenomegaly ()

    Yes
209 (73.1)
77 (26.9)
216.4
<0.0001*

    No
1894 (96.3)
73 (3.7)

Anaemia packed cell volume ()

    Severe (≤15%)
290 (79.9)
73 (20.1)

    Moderate     (16–23%)
291 (82.2)
63 (17.8)

    Mild (24–33%)
863 (91.7)
78 (8.3)

    Normal (>33%)
765 (94.4)
45 (5.6)
81.736
<0.0001*

Statistically significant.

Following bivariate analysis, factors significantly associated with poor treatment outcome () were entered into the regression model and logistic regression analysis carried out. Child’s age less than 12 months (O.R = 5.99, 95% C.I = 1.15–31.15, and ), history of loss of consciousness (O.R = 4.55, 95% CI = 1.72–12.08, and ), and subnormal temperature (O.R = 11.52, 95% CI = 1.07–123.64, and ) were significant predictors of a poorer treatment outcome (Table 5).

Table 5: Multivariate analysis of factors associated with poor treatment outcome.

Odds ratio
95% C.I
value

Sociodemographic characteristics

Age group

    <12
5.99
1.15–31.15
0.033*

    12–23
3.05
0.62–14.88
0.169

    24–35
2.54
0.51–12.65
0.254

    36–47
3.02
0.62–14.80
0.174

    48–59
1

    ≥60
1.08
0.16–6.85
0.939

Mother’s highest level of education

    No formal
0.000
0.000
0.997

    Primary
1.11
0.19–6.57
0.905

    Secondary
1.19
0.23–6.11
0.835

    Tertiary
1

Father’s highest level of education

    No formal
0.000
0.000
0.998

    Primary
1.62
0.31–8.39
0.565

    Secondary
2.0
0.48–8.35
0.342

    Tertiary
1

Illness history given by caregiver

Any drug used prior to presentation

    Yes
1

    No
1.43
0.29–6.93
0.657

Use of PCM prior to presentation

    Yes
1

    No
1.31
0.27–6.44
0.738

Symptoms prior to presentation

    Rigors

        Yes
1

        No
1.51
0.57–4.03
0.409

    Loss of appetite

        Yes
1

        No
1.70
0.78–3.70
0.180

    Vomiting

        Yes
1

        No
0.64
0.31–1.32
0.226

    Jaundice

        Yes
1.26
0.27–5.87
0.767

        No
1

    Pallor

        Yes
1

        No
1.58
0.60–4.13
0.353

    Loss of consciousness

        Yes
4.55
1.72–12.08
0.002*

        No
1

    Convulsion

        Yes
1.61
0.66–3.94
0.296

        No
1

Clinical examination findings

Pallor

    Yes
2.54
0.90–7.16
0.078

    No
1

Jaundice

    Yes
2.05
0.55–7.64
0.284

    No
1

Patients’ temperature

    Febrile
1.89
0.77–4.63
0.163

    Normal
1

    Sub-normal
11.52
1.07–123.64
0.044*

    Hypothermia
—

Hepatomegaly

    Yes
1.17
0.51–2.68
0.709

    No
1

Splenomegaly

    Yes
1.95
0.82–4.62
0.129

    No
1

Respiratory distress

    Yes

    No

Anaemia

    Severe
2.62
0.67–10.18
0.165

    Mild
0.87
0.21–3.72
0.854

    Moderate
1.50
0.45–5.01
0.507

    No anaemia
1

Statistically significant.

4. Discussion

Despite intensified programs in disease control, malaria still remains a public health burden in Sub-Saharan Africa [1]. Although several factors were associated with a poor outcome, after conducting multiple logistic regression analysis, history of loss of consciousness and a child’s age less than 12 months were significant predictors of a poorer treatment outcome. These conditions are recognized as pointers to severe malaria [9] and thus emphasize the need for prompt diagnosis and institution of appropriate treatment in the management of malaria. Children who were less than a year old were the most susceptible to neurological complications or even death after treatment and this susceptibility decreased with increasing age, with the lowest susceptibility recorded among children who aged 48–59 months. Riley et al. noted that, while research suggests that neonates and infants are relatively protected against malaria infection and death from severe malaria, this protection was not infallible and could be undermined in the presence of high transmission [12]. Thus infants could still be infected and could suffer from adverse outcomes and this was in keeping with our study findings. Our study also found that children with subnormal temperature at presentation had poorer outcomes than those with normal temperatures and febrile patients. However, the small number of patients in this subcategory could have accounted for this finding.

The level of education of both the father and mother of the children surveyed was significantly related to the adverse outcome recorded. Gakidou et al. (2010) in their paper on the effect of increased educational attainment on child mortality in 175 countries between 1970 and 2009 noted that the education of women of reproductive age may account for as much as half of the reduction in under-5 mortality observed in their review [13]. Other studies have also found a relationship between higher levels of maternal education and better child heath outcome [14, 15].

Our study suggests a beneficial effect of prior administration of paracetamol as a lower proportion of children who had been given paracetamol developed negative outcomes after treatment compared to their counterparts who were not given paracetamol. Russel et al. (2003) in their review of the use of paracetamol in febrile children submitted that there was no clear evidence in support of its use in treating febrile children [16]. However, early diagnosis of malaria and institution of prompt treatment remain the gold standard for reducing morbidity and mortality from the disease.

Caregivers listed rigors, loss of appetite, vomiting, jaundice, pallor, loss of consciousness, and convulsion as symptoms they observed in their wards. These indicate that many caregivers recognized these symptoms. However more children were noted to be jaundiced, pale, and anaemic on clinical examination and following laboratory investigations conducted at the hospital compared with the caregivers self-report of these symptoms. This implies that many of these symptoms were missed by the caregivers and would therefore explain why a higher percentage of children who were not pale or jaundiced based on their caregivers report had a negative health outcome. This might also explain why a higher percentage of those who had jaundice, pallor, and severe anaemia on clinical examination and/or following laboratory investigations died or developed neurological disorders compared with those who did not have these symptoms or signs.

The study findings also revealed that more children who had not experienced rigors, lost appetite, or vomited had adverse health outcomes. It is thus possible that the caregivers had associated the lack of these symptoms with mild illness leading to delayed presentation at hospital and ultimately delay in commencement of appropriate treatment.

5. Conclusion

A history of loss of consciousness and child’s age less than 12 months were significant predictors of poorer treatment outcome in our study sample. Although the caregivers mentioned a number of symptoms that their children had prior to presentation which were associated with poor outcome, the numbers of children who actually had these symptoms was higher on clinical examination and following laboratory investigation. Many of these symptoms such as pallor, jaundice, and severe anemia were positively associated with adverse treatment outcomes. This has implications for programmes that advocate for home management of malaria because commencement of home management relies on the caregivers ability to recognize mild symptoms of malaria. This approach might be counterproductive as complications may then set in especially when caregivers do not recognize symptoms of severe disease. In view of the study findings, we recommend that caregivers be properly educated so that they can seek medical care promptly in order to prevent progression to severe disease which is associated with poor treatment outcomes.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors are grateful to all study participants and their parents/guardians. They appreciate all the field and laboratory staff of the malaria pathogenesis unit, Institute Child Health, University of Ibadan. The research leading to these results has received funding from the European Community under Grant agreement LSHP-CT-2004-503578.

References

World Health Organization, “World Malaria Report, 2012 Summary,” 2013, http://www.who.int/malaria/publications/world_malaria_report_2012/wmr2012_summary_en.pdf

Federal Ministry of Health, “National Malaria Control Program Strategic Plan 2009–2013,” Federal Ministry of Health, Abuja, Nigeria, 2009

National Population Commission (NPC), “National Malaria Control Programme (NMCP), Measure DHS,” Nigeria Malaria Indicator Survey 2010, 2012

P. W. Njuguna and C. R. J. C. Newton, “Management of severe falciparum malaria,” Journal of Postgraduate Medicine, vol. 50, no. 1, pp. 45–50, 2004.

S. Ahmed, F. Adil, T. Shahzad, and Y. Yahiya, “Severe malaria in children: factors predictive of outcome and response to Quinine,” Journal of the Pakistan Medical Association, vol. 61, no. 1, pp. 54–58, 2011.

S. K. Mishra and C. R. J. C. Newton, “Diagnosis and management of the neurological complications of falciparum malaria,” Nature Reviews Neurology, vol. 5, no. 4, pp. 189–198, 2009.

K. Marsh, D. Forster, C. Waruiru et al., “Indicators of life-threatening malaria in African children,” The New England Journal of Medicine, vol. 332, no. 21, pp. 1399–1404, 1995.

Federal Ministry of Health, “National Antimalarial Treatment Policy,” Federal Ministry of Health, National Malaria and Vector Control Division, Abuja ,Nigeria, May 2005

WHO, “Severe falciparum malaria,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, supplement 1, pp. S1–S90, 2000.

M. Swash, Hutchison's Clinical Methods, ELBS with Bailliere Tindall, London, UK, 19th edition, 1989.

F. J. Kirkham, C. R. J. C. Newton, and W. Whitehouse, “Paediatric coma scales,” Developmental Medicine and Child Neurology, vol. 50, no. 4, pp. 267–274, 2008.

E. M. Riley, G. E. Wagner, B. D. Akanmori, and K. A. Koram, “Do maternally acquired antibodies protect infants from malaria infection?” Parasite Immunology, vol. 23, no. 2, pp. 51–59, 2001.

E. Gakidou, K. Cowling, R. Lozano, and C. J. Murray, “Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis,” The Lancet, vol. 376, no. 9745, pp. 959–974, 2010.

A. R. Joshi, “Maternal schooling and child health: preliminary analysis of the intervening mechanisms in rural Nepal,” Health Transition Review, vol. 4, no. 1, pp. 1–28, 1994.

D. Buor, “Mothers' education and childhood mortality in Ghana,” Health Policy, vol. 64, no. 3, pp. 297–309, 2003.

F. M. Russell, F. Shann, N. Curtis, and K. Mulholland, “Evidence on the use of paracetamol in febrile children,” Bulletin of the World Health Organization, vol. 81, no. 5, pp. 367–372, 2003.